Michael Rosenblatt is of Azenta, Inc.. Currently has a direct ownership of 13,042 shares of AZTA, which is worth approximately $790,997. The most recent transaction as insider was on Feb 12, 2024, when has been sold 2,465 shares (Common) at a price of $65.93 per share, resulting in proceeds of $162,517. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13K
0% 3M change
23.31% 12M change
Total Value Held $790,997

Michael Rosenblatt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 12 2024
BUY
Grant, award, or other acquisition
$162,517 $65.93 p/Share
2,465 Added 15.9%
13,042 Common
Feb 13 2023
BUY
Grant, award, or other acquisition
-
3,604 Added 25.41%
10,577 Common Stock
Feb 11 2022
BUY
Grant, award, or other acquisition
-
1,922 Added 21.61%
6,973 Common Stock
Nov 12 2021
SELL
Open market or private sale
$323,102 $114.13 p/Share
2,831 Reduced 35.92%
5,051 Common Stock
May 13 2021
SELL
Open market or private sale
$158,400 $90.0 p/Share
1,760 Reduced 18.25%
7,882 Common Stock
Feb 05 2021
BUY
Grant, award, or other acquisition
-
1,760 Added 15.44%
9,642 Common Stock

Also insider at

MRK
Merck & Co., Inc. Healthcare
RUBY
Rubius Therapeutics, Inc. Healthcare
AXLA
Axcella Health Inc. Healthcare
MR

Michael Rosenblatt

Kenilworth, NJ

Track Institutional and Insider Activities on AZTA

Follow Azenta, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AZTA shares.

Notify only if

Insider Trading

Get notified when an Azenta, Inc. insider buys or sells AZTA shares.

Notify only if

News

Receive news related to Azenta, Inc.

Track Activities on AZTA